Prescription sampling
Executive Summary
PMA board discusses its opposition to a ban on sampling during March 10 meeting. Although not on the prepared agenda for the meeting, the issue of sampling was raised for discussion. The association says no decision was reached. The PMA board discussion may indicate a willingness by more companies to reconsider the practice of sampling